Does Dr. JAMIL ABOULHOSN have financial conflicts of interest?

Dr. JAMIL ABOULHOSN (MD) has received a total of $312,721 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $312,721 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JAMIL ABOULHOSN?

According to CMS Open Payments data, Dr. JAMIL ABOULHOSN received funding from EDWARDS LIFESCIENCES CORPORATION ($173,372), MEDTRONIC ($105,420), and ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($12,000).

Does Dr. JAMIL ABOULHOSN receive research grants or speaking fees?

Dr. JAMIL ABOULHOSN has received $312,721 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JAMIL ABOULHOSN

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: LOS ANGELES, CA 90024

NPI Number: 1356382717

LIFETIME INDUSTRY VALUE

$312,721

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABOULHOSN is a verified Internal Medicine, Cardiovascular Disease practitioner based in LOS ANGELES, CA.

Between 2021 and 2024, Dr. ABOULHOSN had an overall industry promotional and research financial footprint of $312,721 as recorded in the federal CMS Open Payments database.

$312,721 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABOULHOSN's primary funding source is EDWARDS LIFESCIENCES CORPORATION, which accounts for $173,372 (representing 55.4% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

EDWARDS LIFESCIENCES CORPORATION

Rank 1

$173,372

55.4%

MEDTRONIC

Rank 2

$105,420

33.7%

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 3

$12,000

3.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.